| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.60e-11 | 11 | 117 | 6 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.85e-08 | 32 | 117 | 6 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.57e-07 | 42 | 117 | 6 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.15e-05 | 130 | 117 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 6.37e-05 | 37 | 117 | 4 | GO:0000175 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 8.69e-05 | 40 | 117 | 4 | GO:0016896 | |
| GeneOntologyMolecularFunction | exoribonuclease II activity | 1.02e-04 | 3 | 117 | 2 | GO:0008859 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 1.39e-04 | 45 | 117 | 4 | GO:0004532 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | EXOSC10 DIS3L GATC FARSB DICER1 GGT2P GGT3P FARS2 HELZ2 CNOT1 | 1.73e-04 | 417 | 117 | 10 | GO:0140098 |
| GeneOntologyMolecularFunction | phenylalanine-tRNA ligase activity | 2.03e-04 | 4 | 117 | 2 | GO:0004826 | |
| GeneOntologyMolecularFunction | [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase activity | 3.37e-04 | 5 | 117 | 2 | GO:0004741 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | EXOSC10 DIS3L GATC FARSB REV3L RFC1 DICER1 GGT2P GGT3P FARS2 HELZ2 CNOT1 | 4.06e-04 | 645 | 117 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 4.52e-04 | 61 | 117 | 4 | GO:0008408 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.81e-04 | 62 | 117 | 4 | GO:0016796 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 5.03e-04 | 6 | 117 | 2 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 5.03e-04 | 6 | 117 | 2 | GO:0002951 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 7.01e-04 | 7 | 117 | 2 | GO:0008467 | |
| GeneOntologyMolecularFunction | uridylyltransferase activity | 7.01e-04 | 7 | 117 | 2 | GO:0070569 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 9.31e-04 | 8 | 117 | 2 | GO:0103068 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 ACTB RFC1 DNAH7 DICER1 CCT8L2 KIF3B HELZ2 MACF1 CCT8L1P DNAH11 | 9.69e-04 | 614 | 117 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.19e-03 | 9 | 117 | 2 | GO:0036374 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.24e-03 | 136 | 117 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 1.60e-03 | 144 | 117 | 5 | GO:0140101 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.07e-03 | 303 | 117 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | exonuclease activity | 2.10e-03 | 92 | 117 | 4 | GO:0004527 | |
| GeneOntologyMolecularFunction | profilin binding | 2.55e-03 | 13 | 117 | 2 | GO:0005522 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.92e-08 | 31 | 117 | 6 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 4.15e-08 | 35 | 117 | 6 | GO:0099188 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle endocytosis | 3.54e-05 | 33 | 117 | 4 | GO:1900242 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 7.49e-05 | 313 | 117 | 9 | GO:0099173 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | POTEF FAT3 ACTB LRRK2 ACTG1 POTEKP NLGN1 PTCH1 BTBD3 POTEE IGF1R MACF1 RERE POTEI | 8.76e-05 | 748 | 117 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle recycling | 1.12e-04 | 44 | 117 | 4 | GO:1903421 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | RHOJ POTEF FAT3 ACTB LRRK2 ACTG1 POTEKP NLGN1 PTCH1 DICER1 BTBD3 POTEE FRY IGF1R MACF1 RERE POTEI FMNL1 | 1.33e-04 | 1194 | 117 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | POTEF ACTB LRRK2 ACTG1 POTEKP NLGN1 PTCH1 DICER1 BTBD3 POTEE IGF1R MACF1 RERE POTEI | 1.81e-04 | 802 | 117 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 1.90e-04 | 4 | 117 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | phenylalanyl-tRNA aminoacylation | 1.90e-04 | 4 | 117 | 2 | GO:0006432 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 2.18e-04 | 96 | 117 | 5 | GO:0048488 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | POTEF ACTB LRRK2 ACTG1 POTEKP NLGN1 PTCH1 DICER1 BTBD3 POTEE IGF1R MACF1 RERE POTEI | 2.25e-04 | 819 | 117 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | POTEF ACTB LRRK2 ACTG1 POTEKP NLGN1 PTCH1 DICER1 BTBD3 POTEE IGF1R MACF1 RERE POTEI | 2.45e-04 | 826 | 117 | 14 | GO:0048858 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 4.57e-10 | 32 | 118 | 7 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 4.57e-10 | 32 | 118 | 7 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 5.80e-09 | 45 | 118 | 7 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.04e-06 | 94 | 118 | 7 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.06e-06 | 104 | 118 | 7 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.83e-06 | 109 | 118 | 7 | GO:1902493 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | ZSWIM5 POTEF ACTB GATC ACTG1 FAM98A POTEKP PATL1 REV3L TRRAP DICER1 POTEE CCT8L2 PDRG1 LMO7 POTEI CCT8L1P CNOT1 | 8.53e-06 | 972 | 118 | 18 | GO:0140535 |
| GeneOntologyCellularComponent | actin filament | 1.82e-04 | 146 | 118 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | axon | ABR POTEF LRFN3 ACTB LRRK2 ACTG1 POTEKP PTCH1 DICER1 PTPN5 POTEE IGF1R KIF3B POTEI | 5.02e-04 | 891 | 118 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | dense body | 6.51e-04 | 7 | 118 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | intraciliary transport particle A | 8.65e-04 | 8 | 118 | 2 | GO:0030991 | |
| GeneOntologyCellularComponent | blood microparticle | 1.36e-03 | 144 | 118 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | alveolar lamellar body | 1.38e-03 | 10 | 118 | 2 | GO:0097208 | |
| GeneOntologyCellularComponent | multivesicular body | 1.56e-03 | 88 | 118 | 4 | GO:0005771 | |
| GeneOntologyCellularComponent | chaperonin-containing T-complex | 1.68e-03 | 11 | 118 | 2 | GO:0005832 | |
| GeneOntologyCellularComponent | protein folding chaperone complex | 1.71e-03 | 42 | 118 | 3 | GO:0101031 | |
| Domain | Actin_CS | 3.45e-10 | 16 | 114 | 6 | IPR004001 | |
| Domain | ACTINS_2 | 5.31e-10 | 17 | 114 | 6 | PS00432 | |
| Domain | Actin/actin-like_CS | 7.92e-10 | 18 | 114 | 6 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.15e-09 | 19 | 114 | 6 | PS01132 | |
| Domain | Actin | 2.94e-08 | 31 | 114 | 6 | IPR004000 | |
| Domain | Actin | 2.94e-08 | 31 | 114 | 6 | PF00022 | |
| Domain | ACTIN | 2.94e-08 | 31 | 114 | 6 | SM00268 | |
| Domain | ACTINS_1 | 1.21e-05 | 8 | 114 | 3 | PS00406 | |
| Domain | COR | 3.69e-05 | 2 | 114 | 2 | IPR032171 | |
| Domain | COR | 3.69e-05 | 2 | 114 | 2 | PF16095 | |
| Domain | RNase_II/R_CS | 2.20e-04 | 4 | 114 | 2 | IPR022966 | |
| Domain | ROC_dom | 2.20e-04 | 4 | 114 | 2 | IPR020859 | |
| Domain | ROC | 2.20e-04 | 4 | 114 | 2 | PS51424 | |
| Domain | ARM-type_fold | 2.34e-04 | 339 | 114 | 9 | IPR016024 | |
| Domain | PHR | 3.65e-04 | 5 | 114 | 2 | IPR012983 | |
| Domain | PHR | 3.65e-04 | 5 | 114 | 2 | PF08005 | |
| Domain | - | ABCA3 NWD1 RHOJ LRRK2 LRRK1 RFC1 DNAH7 DICER1 AK7 HELZ2 HS3ST2 HS3ST1 DNAH11 | 6.26e-04 | 746 | 114 | 13 | 3.40.50.300 |
| Domain | P-loop_NTPase | ABCA3 NWD1 RHOJ LRRK2 LRRK1 RFC1 DNAH7 DICER1 AK7 KIF3B HELZ2 HS3ST2 HS3ST1 DNAH11 | 6.55e-04 | 848 | 114 | 14 | IPR027417 |
| Domain | ARM-like | 1.35e-03 | 270 | 114 | 7 | IPR011989 | |
| Domain | Kinase-like_dom | 1.79e-03 | 542 | 114 | 10 | IPR011009 | |
| Domain | AAA | 1.90e-03 | 144 | 114 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.90e-03 | 144 | 114 | 5 | IPR003593 | |
| Domain | PP2C_BS | 2.34e-03 | 12 | 114 | 2 | IPR000222 | |
| Domain | - | 2.42e-03 | 222 | 114 | 6 | 1.25.10.10 | |
| Domain | MIRO-like | 2.76e-03 | 13 | 114 | 2 | IPR013684 | |
| Domain | Roc | 2.76e-03 | 13 | 114 | 2 | PF08477 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.20e-03 | 14 | 114 | 2 | IPR024317 | |
| Domain | PP2C_SIG | 3.20e-03 | 14 | 114 | 2 | SM00331 | |
| Domain | Dynein_HC_stalk | 3.20e-03 | 14 | 114 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.20e-03 | 14 | 114 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.20e-03 | 14 | 114 | 2 | PF08393 | |
| Domain | MT | 3.20e-03 | 14 | 114 | 2 | PF12777 | |
| Domain | AAA_8 | 3.20e-03 | 14 | 114 | 2 | PF12780 | |
| Domain | DHC_fam | 3.68e-03 | 15 | 114 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.68e-03 | 15 | 114 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.68e-03 | 15 | 114 | 2 | IPR004273 | |
| Domain | PPM_1 | 3.68e-03 | 15 | 114 | 2 | PS01032 | |
| Domain | L_dom-like | 4.01e-03 | 328 | 114 | 7 | IPR032675 | |
| Domain | - | 4.17e-03 | 248 | 114 | 6 | 1.25.40.20 | |
| Domain | Ankyrin_rpt-contain_dom | 4.69e-03 | 254 | 114 | 6 | IPR020683 | |
| Domain | PP2C | 4.73e-03 | 17 | 114 | 2 | IPR015655 | |
| Domain | Ankyrin_rpt | 5.44e-03 | 262 | 114 | 6 | IPR002110 | |
| Domain | BACK | 5.89e-03 | 60 | 114 | 3 | SM00875 | |
| Domain | PP2C | 5.90e-03 | 19 | 114 | 2 | PF00481 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.89e-14 | 15 | 119 | 7 | 16824795 | |
| Pubmed | POTEF ACTB LRRK2 MED14 ACTG1 ACTG2 POTEKP NEK4 POTEE SF3B1 SLC25A13 TTC21B OSMR HECTD1 RABGGTA | 2.82e-10 | 513 | 119 | 15 | 25798074 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | EXOSC10 POTEF ACTB ACTG1 ACTG2 POTEKP RFC1 POTEE GTF2I SF3B1 POTEI | 2.63e-09 | 271 | 119 | 11 | 32433965 |
| Pubmed | 3.51e-08 | 202 | 119 | 9 | 24639526 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 POTEF FAM98A MAP3K6 DNAH7 NEK4 FSIP2 LRPPRC IGF1R LMO7 DSTYK SYNE2 DYRK1B MACF1 HECTD1 DOP1B | 4.34e-08 | 861 | 119 | 16 | 36931259 |
| Pubmed | 4.93e-08 | 149 | 119 | 8 | 22664934 | ||
| Pubmed | EXOSC10 RFC1 TRRAP DICER1 LRPPRC GTF2I SF3B1 SLC25A13 SYNE2 HELZ2 MACF1 HECTD1 CNOT1 XPOT | 5.70e-08 | 653 | 119 | 14 | 22586326 | |
| Pubmed | 6.48e-08 | 102 | 119 | 7 | 10231032 | ||
| Pubmed | POTEF ACTB ACTG1 FARSB ACTG2 BUD13 FAM98A POTEKP DNAH7 AK7 POTEE LRPPRC GTF2I SF3B1 SLC25A13 PDP2 MACF1 POTEI | 8.04e-08 | 1153 | 119 | 18 | 29845934 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 7.75e-07 | 6 | 119 | 3 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 7.75e-07 | 6 | 119 | 3 | 10074138 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 7.75e-07 | 6 | 119 | 3 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 7.75e-07 | 6 | 119 | 3 | 1540415 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 8761950 | ||
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 7.75e-07 | 6 | 119 | 3 | 11709093 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 10049817 | ||
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 7.75e-07 | 6 | 119 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 7.75e-07 | 6 | 119 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 7.75e-07 | 6 | 119 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 7.75e-07 | 6 | 119 | 3 | 8661406 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 23017337 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 7.75e-07 | 6 | 119 | 3 | 23875777 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 9841925 | ||
| Pubmed | 1.02e-06 | 96 | 119 | 6 | 23580065 | ||
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 22535526 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 1.35e-06 | 7 | 119 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 1.35e-06 | 7 | 119 | 3 | 22640593 | |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 1.35e-06 | 7 | 119 | 3 | 17504171 | |
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 22465675 | ||
| Pubmed | CYLC2 ZSWIM5 POTEF ACTB ACTG1 ACTG2 FAM98A RYR2 POTEE LRPPRC SF3B1 LMO7 SLC25A13 SYNE2 UGP2 MACF1 CFAP74 POTEI | 2.05e-06 | 1442 | 119 | 18 | 35575683 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | EXOSC10 MED14 FARSB BUD13 FAM98A RFC1 TRRAP UPF2 SLC25A13 NEMF MACF1 HECTD1 CNOT1 | 2.15e-06 | 759 | 119 | 13 | 35915203 |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 14694110 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 20147394 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 23260110 | ||
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 3.23e-06 | 9 | 119 | 3 | 10556093 | |
| Pubmed | 3.23e-06 | 9 | 119 | 3 | 16364570 | ||
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 3.23e-06 | 9 | 119 | 3 | 8892894 | |
| Pubmed | 3.23e-06 | 9 | 119 | 3 | 18775311 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SLC25A42 FAM98A PATL1 RFC1 DICER1 RYR2 FRY KIF3B CNOT1 GABRA1 | 4.55e-06 | 462 | 119 | 10 | 31138677 |
| Pubmed | 4.61e-06 | 10 | 119 | 3 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 4.61e-06 | 10 | 119 | 3 | 1991513 | |
| Pubmed | 4.61e-06 | 10 | 119 | 3 | 23575248 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | ACTB HLCS PTPN5 LRPPRC GTF2I SF3B1 PDRG1 SLC25A13 POTEI DOP1B XPOT | 4.68e-06 | 573 | 119 | 11 | 28330616 |
| Pubmed | 6.28e-06 | 35 | 119 | 4 | 20946988 | ||
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 6.32e-06 | 11 | 119 | 3 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 6.32e-06 | 11 | 119 | 3 | 19639585 | |
| Pubmed | IFT140 DIS3L FAT3 HLCS BUD13 REV3L TRRAP DICER1 TYK2 GFOD1 SLC25A13 MACF1 RERE KDM1B OSMR | 6.59e-06 | 1116 | 119 | 15 | 31753913 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EXOSC10 ACTB ACTG1 FARSB FAM98A PATL1 RFC1 LRPPRC GTF2I SF3B1 PDRG1 SLC25A13 SYNE2 NEMF MACF1 HECTD1 XPOT | 6.72e-06 | 1415 | 119 | 17 | 28515276 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | EXOSC10 ACTB FAM98A RFC1 TYK2 LRPPRC SF3B1 UPF2 SLC25A13 NEMF | 7.08e-06 | 486 | 119 | 10 | 30940648 |
| Pubmed | 8.40e-06 | 12 | 119 | 3 | 14527413 | ||
| Pubmed | 8.40e-06 | 12 | 119 | 3 | 23071112 | ||
| Pubmed | Lessons on conditional gene targeting in mouse adipose tissue. | 8.40e-06 | 12 | 119 | 3 | 23321074 | |
| Pubmed | 1.08e-05 | 40 | 119 | 4 | 32317081 | ||
| Pubmed | 1.09e-05 | 13 | 119 | 3 | 23349485 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 1.16e-05 | 2 | 119 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 1.16e-05 | 2 | 119 | 2 | 22366783 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18272292 | ||
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 1.16e-05 | 2 | 119 | 2 | 32588558 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27625340 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35534227 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17394548 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.16e-05 | 2 | 119 | 2 | 19669888 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 3221869 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17540762 | ||
| Pubmed | Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions? | 1.16e-05 | 2 | 119 | 2 | 22988872 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 2747639 | ||
| Pubmed | Genetic Analysis of LRRK1 and LRRK2 Variants in Essential Tremor Patients. | 1.16e-05 | 2 | 119 | 2 | 29812962 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21502360 | ||
| Pubmed | Dynamic and redundant regulation of LRRK2 and LRRK1 expression. | 1.16e-05 | 2 | 119 | 2 | 18045479 | |
| Pubmed | Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease. | 1.16e-05 | 2 | 119 | 2 | 20144646 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 6686106 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 213279 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33334799 | ||
| Pubmed | Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. | 1.16e-05 | 2 | 119 | 2 | 17225181 | |
| Pubmed | Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway. | 1.16e-05 | 2 | 119 | 2 | 17324517 | |
| Pubmed | β-Actin specifically controls cell growth, migration, and the G-actin pool. | 1.16e-05 | 2 | 119 | 2 | 21900491 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26773048 | ||
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 1.16e-05 | 2 | 119 | 2 | 19638415 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 1.16e-05 | 2 | 119 | 2 | 3335520 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9288906 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 1577857 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9651365 | ||
| Pubmed | Delayed embryonic development and impaired cell growth and survival in Actg1 null mice. | 1.16e-05 | 2 | 119 | 2 | 20662086 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26583190 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32326615 | ||
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 1.16e-05 | 2 | 119 | 2 | 23756437 | |
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 1.16e-05 | 2 | 119 | 2 | 8482333 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33132310 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29265728 | ||
| Pubmed | Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. | 1.16e-05 | 2 | 119 | 2 | 22246323 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20208177 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 2837653 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32349449 | ||
| Pubmed | Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings. | 1.16e-05 | 2 | 119 | 2 | 32506774 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33459343 | ||
| Pubmed | Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. | 1.16e-05 | 2 | 119 | 2 | 20847274 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 37845194 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29056298 | ||
| Interaction | ACTG2 interactions | 4.01e-10 | 49 | 118 | 8 | int:ACTG2 | |
| Interaction | DUSP15 interactions | 1.16e-09 | 35 | 118 | 7 | int:DUSP15 | |
| Interaction | NEK4 interactions | POTEF ACTB LRRK2 MED14 ACTG1 ACTG2 POTEKP NEK4 POTEE SF3B1 SLC25A13 TTC21B OSMR HECTD1 RABGGTA | 1.58e-06 | 582 | 118 | 15 | int:NEK4 |
| Interaction | LGR4 interactions | 3.30e-06 | 262 | 118 | 10 | int:LGR4 | |
| Interaction | POTEJ interactions | 1.32e-05 | 52 | 118 | 5 | int:POTEJ | |
| Interaction | SCIN interactions | 2.26e-05 | 58 | 118 | 5 | int:SCIN | |
| Interaction | DUSP26 interactions | 2.46e-05 | 59 | 118 | 5 | int:DUSP26 | |
| Interaction | SIRT7 interactions | EXOSC10 MAGED1 RFC1 TRRAP DICER1 LRPPRC GTF2I SF3B1 SLC25A13 SYNE2 HELZ2 MACF1 HECTD1 CNOT1 XPOT | 2.96e-05 | 744 | 118 | 15 | int:SIRT7 |
| Interaction | ADARB1 interactions | EXOSC10 POTEF ACTB ACTG1 ACTG2 BUD13 POTEKP RFC1 LRPPRC GTF2I SF3B1 POTEI | 3.03e-05 | 489 | 118 | 12 | int:ADARB1 |
| Interaction | ERRFI1 interactions | 3.96e-05 | 107 | 118 | 6 | int:ERRFI1 | |
| Interaction | ACTA2 interactions | 4.58e-05 | 355 | 118 | 10 | int:ACTA2 | |
| Cytoband | 2q21.1 | 1.63e-05 | 58 | 119 | 4 | 2q21.1 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 2.11e-07 | 13 | 77 | 4 | 685 | |
| GeneFamily | Actins | 1.47e-06 | 6 | 77 | 3 | 929 | |
| GeneFamily | Exosome complex | 1.15e-03 | 12 | 77 | 2 | 817 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 1.35e-03 | 13 | 77 | 2 | 564 | |
| GeneFamily | Dyneins, axonemal | 2.34e-03 | 17 | 77 | 2 | 536 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 2.34e-03 | 17 | 77 | 2 | 701 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 2.92e-03 | 19 | 77 | 2 | 132 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 4.65e-03 | 24 | 77 | 2 | 615 | |
| GeneFamily | Fibronectin type III domain containing | 4.84e-03 | 160 | 77 | 4 | 555 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 REV3L TRRAP DICER1 EFR3A NEK4 LRPPRC IGF1R UPF2 FARS2 SLC25A13 SYNE2 MACF1 OSMR DOP1B | 7.98e-06 | 856 | 119 | 15 | M4500 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | EXOSC10 SLC25A42 ABR GALT ORC6 FARSB TRRAP DICER1 TYK2 SF3B1 GFOD1 ZMIZ2 HELZ2 D2HGDH DOP1B | 1.54e-05 | 905 | 119 | 15 | M40865 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.26e-07 | 183 | 119 | 7 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 9.92e-07 | 196 | 119 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 9.92e-07 | 196 | 119 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-06 | 127 | 119 | 6 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-06 | 148 | 119 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-06 | 148 | 119 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 165 | 119 | 6 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 165 | 119 | 6 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-06 | 168 | 119 | 6 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-06 | 168 | 119 | 6 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.45e-06 | 178 | 119 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.72e-06 | 179 | 119 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 9.59e-06 | 182 | 119 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-05 | 184 | 119 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-05 | 185 | 119 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.05e-05 | 185 | 119 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-05 | 185 | 119 | 6 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.05e-05 | 185 | 119 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.08e-05 | 186 | 119 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.08e-05 | 186 | 119 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.12e-05 | 187 | 119 | 6 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-05 | 187 | 119 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.12e-05 | 187 | 119 | 6 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 188 | 119 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.15e-05 | 188 | 119 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.15e-05 | 188 | 119 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-05 | 188 | 119 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.15e-05 | 188 | 119 | 6 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 189 | 119 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.19e-05 | 189 | 119 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.19e-05 | 189 | 119 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.19e-05 | 189 | 119 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-05 | 191 | 119 | 6 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-05 | 191 | 119 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-05 | 191 | 119 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-05 | 191 | 119 | 6 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-05 | 191 | 119 | 6 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-05 | 191 | 119 | 6 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.26e-05 | 191 | 119 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-05 | 191 | 119 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-05 | 191 | 119 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-05 | 191 | 119 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-05 | 191 | 119 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 191 | 119 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 1.26e-05 | 191 | 119 | 6 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-05 | 191 | 119 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.34e-05 | 193 | 119 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.34e-05 | 193 | 119 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.34e-05 | 193 | 119 | 6 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-05 | 193 | 119 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.38e-05 | 194 | 119 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.38e-05 | 194 | 119 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.38e-05 | 194 | 119 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.42e-05 | 195 | 119 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-05 | 195 | 119 | 6 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-05 | 195 | 119 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.42e-05 | 195 | 119 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.42e-05 | 195 | 119 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.42e-05 | 195 | 119 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.46e-05 | 196 | 119 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.50e-05 | 197 | 119 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.50e-05 | 197 | 119 | 6 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.50e-05 | 197 | 119 | 6 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.55e-05 | 198 | 119 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 198 | 119 | 6 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 198 | 119 | 6 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 199 | 119 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-05 | 151 | 119 | 5 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-05 | 151 | 119 | 5 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-05 | 154 | 119 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-05 | 154 | 119 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.06e-05 | 155 | 119 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.06e-05 | 155 | 119 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 159 | 119 | 5 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.14e-05 | 165 | 119 | 5 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | Tuft-tuft-1|World / Class top | 8.86e-05 | 168 | 119 | 5 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 169 | 119 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-05 | 170 | 119 | 5 | b180ec9a1b79025a180c8559c27c31272410dea8 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-05 | 170 | 119 | 5 | 37c647f67505aa1ff12a198df1eeddd9f406fe15 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.90e-05 | 172 | 119 | 5 | 41ddfb316429efef5f3fa0b0621ced383d9206f0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 177 | 119 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 177 | 119 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-04 | 179 | 119 | 5 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | Ciliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-04 | 179 | 119 | 5 | 1c41314b6fcfcac8d62034e7037570120d58f20f | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 1.22e-04 | 180 | 119 | 5 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.22e-04 | 180 | 119 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.22e-04 | 180 | 119 | 5 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-04 | 181 | 119 | 5 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-04 | 181 | 119 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-04 | 181 | 119 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 96 | 119 | 4 | 9e31d5ed093cf8ff49a315339c1b60d63b27666b | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 96 | 119 | 4 | a1847fec63ba96c11c4074a78a8b3a45cf5b6d6f | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 96 | 119 | 4 | e83a910187569d7c53d35cc094da1d166bf6f5b2 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.29e-04 | 182 | 119 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 183 | 119 | 5 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| Drug | tyrosinyl-5'-AMP | 2.50e-06 | 19 | 118 | 4 | CID000169008 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.51e-08 | 8 | 115 | 4 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.51e-08 | 8 | 115 | 4 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.51e-08 | 8 | 115 | 4 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.51e-08 | 8 | 115 | 4 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:13832 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome | 1.51e-05 | 2 | 115 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 1.51e-05 | 2 | 115 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 1.51e-05 | 2 | 115 | 2 | C1853623 | |
| Disease | Hyaline Membrane Disease | 4.51e-05 | 3 | 115 | 2 | C0020192 | |
| Disease | Respiratory Distress Syndrome | 4.51e-05 | 3 | 115 | 2 | C0852283 | |
| Disease | Hereditary pulmonary alveolar proteinosis | 8.99e-05 | 4 | 115 | 2 | cv:C3711368 | |
| Disease | diacylglycerol 44:6 measurement | 1.49e-04 | 5 | 115 | 2 | EFO_0020070 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 1.65e-04 | 70 | 115 | 4 | EFO_0008082 | |
| Disease | Respiratory Distress Syndrome, Newborn | 2.24e-04 | 6 | 115 | 2 | C0035220 | |
| Disease | pulmonary alveolar proteinosis (is_implicated_in) | 2.24e-04 | 6 | 115 | 2 | DOID:12120 (is_implicated_in) | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 2.24e-04 | 6 | 115 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | Uveoretinal Coloboma | 3.12e-04 | 7 | 115 | 2 | C4554007 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 3.12e-04 | 7 | 115 | 2 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 4.15e-04 | 8 | 115 | 2 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | holoprosencephaly (is_implicated_in) | 4.15e-04 | 8 | 115 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | overall survival | 5.32e-04 | 9 | 115 | 2 | EFO_0000638 | |
| Disease | Congenital ocular coloboma (disorder) | 5.32e-04 | 9 | 115 | 2 | C0009363 | |
| Disease | Congenital neurologic anomalies | 6.64e-04 | 10 | 115 | 2 | C0497552 | |
| Disease | Cranioschisis | 6.64e-04 | 10 | 115 | 2 | C0265541 | |
| Disease | Jeune thoracic dystrophy | 8.09e-04 | 11 | 115 | 2 | C0265275 | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 8.09e-04 | 11 | 115 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | Malignant mesothelioma | 8.89e-04 | 109 | 115 | 4 | C0345967 | |
| Disease | Short Rib-Polydactyly Syndrome | 1.14e-03 | 13 | 115 | 2 | C0036996 | |
| Disease | Saldino-Noonan Syndrome | 1.33e-03 | 14 | 115 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 1.33e-03 | 14 | 115 | 2 | C0024507 | |
| Disease | amino acid measurement | 1.37e-03 | 678 | 115 | 9 | EFO_0005134 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.53e-03 | 15 | 115 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Rhabdomyosarcoma | 1.53e-03 | 15 | 115 | 2 | C0035412 | |
| Disease | behavioural inhibitory control measurement | 1.74e-03 | 16 | 115 | 2 | EFO_0008467 | |
| Disease | cutaneous melanoma, hair color | 1.84e-03 | 62 | 115 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Global developmental delay | 1.85e-03 | 133 | 115 | 4 | C0557874 | |
| Disease | Intellectual Disability | 1.88e-03 | 447 | 115 | 7 | C3714756 | |
| Disease | lifestyle measurement | 2.32e-03 | 235 | 115 | 5 | EFO_0010724 | |
| Disease | C-reactive protein measurement | DOCK4 NUP210L GATC NLGN1 AK7 GTF2I UBP1 DSTYK ZMIZ2 MACF1 RERE DNAH11 | 2.64e-03 | 1206 | 115 | 12 | EFO_0004458 |
| Disease | cognitive function measurement, self reported educational attainment | 2.73e-03 | 355 | 115 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | Paroxysmal atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C2585653 | |
| Disease | Lung diseases | 3.55e-03 | 78 | 115 | 3 | C0024115 | |
| Disease | Atrial Fibrillation | 3.61e-03 | 160 | 115 | 4 | C0004238 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.61e-03 | 23 | 115 | 2 | C1335177 | |
| Disease | Headache, type 2 diabetes mellitus | 3.61e-03 | 23 | 115 | 2 | HP_0002315, MONDO_0005148 | |
| Disease | frailty measurement | 3.61e-03 | 23 | 115 | 2 | EFO_0009885 | |
| Disease | asthma, allergic disease | 3.68e-03 | 79 | 115 | 3 | MONDO_0004979, MONDO_0005271 | |
| Disease | Endometrioma | 3.69e-03 | 161 | 115 | 4 | C0269102 | |
| Disease | Endometriosis | 3.69e-03 | 161 | 115 | 4 | C0014175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKPDNYMTLSRLIDL | 981 | Q7Z4L5 | |
| TMEALLYKPIDRVTR | 231 | Q12979 | |
| PLARYIDDEDLDRML | 521 | Q9BRD0 | |
| RALYLVRIPTMTLEE | 331 | Q96KE9 | |
| LRLDLAGRELTDYLM | 176 | Q9BYX7 | |
| LRLDLAGRDLTDYLM | 176 | P60709 | |
| LRLDLAGRDLTDYLM | 176 | P63261 | |
| DYSPNELLRMELAIL | 226 | Q6ZMN8 | |
| ERIALTPFMRLLFEI | 2286 | Q96DT5 | |
| YSSELFDDPMLRLTL | 946 | Q99758 | |
| ALYLIRIPTMALDDF | 316 | Q9Y2F9 | |
| IMRLDLAGRDLTDYL | 176 | P63267 | |
| LMRISERPSVYLAAR | 81 | Q14093 | |
| TDRSGLYERLLMELE | 261 | Q9UPY3 | |
| PLSRDILMETLLYEQ | 6 | Q13323 | |
| DLVLRMLEYEPAARI | 406 | Q9Y463 | |
| SPSLMEDYELRQLVL | 466 | Q14156 | |
| RGMERSLLYTELLAR | 801 | Q149M9 | |
| MLSPEAERVLRYLVE | 1 | Q9NUG6 | |
| LSELEPATEYMARVR | 391 | Q99650 | |
| LMSPREESAREYLLS | 266 | P54829 | |
| ERLTLPRLADTYEML | 206 | A6NGU5 | |
| LRLDLAGRELPDYLM | 876 | A5A3E0 | |
| RRYLLSLEEERPALM | 541 | Q86TB9 | |
| YRSLMPRTLESQITL | 161 | Q9Y278 | |
| PIKRSEMLRDIIREY | 491 | Q9Y5V3 | |
| EPMESVLEDRCLYLR | 76 | O43716 | |
| VTMLLRNPYLLSEEE | 406 | O60524 | |
| EMVRYLLSKRLVELP | 101 | Q38SD2 | |
| LLLLERVPAMSYVSI | 371 | P14672 | |
| LEDYMALFPSVRILR | 196 | Q86SR1 | |
| LLAEVLASLLDMVYR | 1901 | Q9Y3R5 | |
| LYLLSAAEEIRDPLM | 386 | P50747 | |
| TVLPHSLLEDMVYRL | 5111 | Q5CZC0 | |
| DLKSYLRSLRPEMEN | 1086 | P08069 | |
| LLSPDIIMNLLLSYR | 271 | O95382 | |
| MPRDYSPELAELIRT | 226 | P51957 | |
| RDKLQDRMSPYLVSL | 541 | P31512 | |
| YRRDDLEMAALDPDL | 496 | Q8WWI1 | |
| SRLINRLLEISPYML | 1706 | Q5S007 | |
| RLLEISPYMLSGRER | 1711 | Q5S007 | |
| ERRYIPDAMNLILLL | 331 | P42704 | |
| LRITEDGTLLYTMRL | 146 | P14867 | |
| DDILVYRMIPAESRS | 466 | Q9BTN0 | |
| YRMIPAESRSFLLTD | 471 | Q9BTN0 | |
| LVLDARSDLPTAMEY | 791 | Q9UKX5 | |
| DYTLAMRRSPDDVPL | 801 | Q8N2Q7 | |
| EPLSMLQRLTEDLEY | 546 | Q969R2 | |
| LPEELARMYRDDITI | 506 | Q9P0J1 | |
| DLRDDPKTLARLLYM | 136 | Q9H4E5 | |
| MESERSPLYRQLIDL | 296 | Q6XUX3 | |
| MSRLTPERNLDLERY | 1231 | Q9UPN3 | |
| RAYSELMVLTDLLPR | 61 | O60244 | |
| LRLDLAGRELPDYLM | 876 | Q6S8J3 | |
| LTLPEDLARMYRDDI | 496 | Q9P2J9 | |
| IRPLPEEMLSYARDD | 426 | Q01780 | |
| PEYSSEEIMRERLLA | 2586 | Q9ULT8 | |
| ILDTMYPELSARART | 1751 | Q9Y2F5 | |
| IYPELMDLRSRTTPI | 531 | Q9NPB8 | |
| SRDPTMYLALRNLIL | 301 | Q8NB78 | |
| MPTIERATLTRDFYL | 416 | P51878 | |
| LIATVTRLMERLLDY | 1151 | Q8N1I0 | |
| TRMVHLERLIPDTLY | 1986 | Q99715 | |
| IALPSLRILYMTDEV | 76 | P00403 | |
| EVDYAPSLMARLILE | 91 | Q9Y2V0 | |
| PSLMARLILERFLQE | 96 | Q9Y2V0 | |
| EDYIPASLIERMTAL | 496 | Q68DX3 | |
| PLLMEYSRQELLRKE | 216 | P07902 | |
| TTERFLPLLRMRLDD | 256 | P14061 | |
| LADRRYDMLPSVLSA | 531 | Q8TF46 | |
| PTLDTIRYSALMELL | 1951 | Q8WXX0 | |
| LDRERIPVYSLMAKA | 3091 | Q8TDW7 | |
| MEELREILSSLLPFV | 506 | Q9P203 | |
| VRASERLAEIDMPYL | 51 | Q8N1E2 | |
| LLMRFLPTEYERSLI | 751 | O95466 | |
| DPKMARVALESLYRL | 396 | Q5TBA9 | |
| TYTLAMASLEVIRRP | 551 | Q9BYK8 | |
| KAPSYLEISSMRRIL | 916 | P78347 | |
| LIMNLSRDAYEIRLL | 131 | O96011 | |
| LEESSGYMEPTLRIL | 4561 | Q92736 | |
| RMLSEDLPSLELYVN | 936 | Q96RY7 | |
| LEMRKRELRPSSDEY | 1166 | Q9C0B2 | |
| ELSRYVEERDFIMPL | 176 | Q8N465 | |
| ERLTLPRLADTYEML | 206 | P36268 | |
| RARELYVDDSPLELM | 136 | Q5VU65 | |
| YVDDSPLELMVRALD | 141 | Q5VU65 | |
| DIDYMISDTLELLRP | 971 | Q9HAU5 | |
| ADEPRMSIRAIYLAI | 416 | A6NES4 | |
| ERVYSMNPSIRLLLI | 131 | O14792 | |
| LLIRRTELLMAYLEA | 591 | Q8NAN2 | |
| ERYSVILLDTLLGRM | 251 | P07988 | |
| MSSLPLSYREALERL | 3386 | Q8WXH0 | |
| LSPAYLISEAMRRSR | 371 | Q9NXC2 | |
| MDYLSLLRDALVQPL | 996 | P35251 | |
| LLTYLISELEAARML | 111 | Q8NCA5 | |
| LMRALDPLLYEKETL | 391 | Q92696 | |
| IFPAILSMDLYRRED | 591 | Q13635 | |
| PSDIRDYVMLRSAIL | 231 | Q9UJ37 | |
| MEIIYLSEVLDTPLL | 321 | A6NM43 | |
| MEIIYLSEVLDTPLL | 321 | Q96SF2 | |
| AEPDMLRKAEEYLRL | 16 | Q9Y5N6 | |
| LRLDLAGRELTDYLM | 876 | P0CG38 | |
| LRPEMSYPDRLAAER | 1386 | Q9P2R6 | |
| ASLTYPLDLVRARMA | 146 | Q86VD7 | |
| RETPENLAKLLTRMY | 321 | Q9NSD9 | |
| SYDLEPFLRRLGMID | 276 | P50452 | |
| ADLYEPRGRMTLADI | 276 | Q9UJS0 | |
| LLYPEKRDILMDRIL | 226 | A5YKK6 | |
| DYLRRFESIPDMLEL | 441 | Q16851 | |
| DPDLSYKLALRAMRL | 751 | Q9P217 | |
| PALELTRKMLTYDRR | 2926 | O60673 | |
| VLLELDMPSRTTRDY | 661 | O15066 | |
| IYAVTPLLEDALMDR | 1166 | O75533 | |
| LRDSVYKTLIMRPDL | 451 | Q8NF64 | |
| PSYLSEIEMLLAIEI | 1581 | Q8N9V7 | |
| YDTTILTEMRLEPII | 266 | Q9NZI7 | |
| LYLRILMAIDSELVD | 141 | O43592 | |
| LARAMDPEAEVLLAY | 336 | P51687 | |
| LERLAMILYDIPDIR | 316 | O95363 | |
| ATILVEYLLDRLPEM | 686 | Q9Y4A5 | |
| RFPALETLMLDDNRL | 226 | Q6P2D8 | |
| LEIPRDASLMLYFRI | 91 | P29597 | |
| TYSAISREDLLMRLL | 96 | Q96M32 | |
| LLDMVENYPTALRSL | 221 | Q5JTD7 |